Answer
Rifampicin, a strong CYP3A inducer, decreased naldemedine tosylate exposure by 83%, and concomitant use is not recommended.
Sources for this answer
- Rizmoic 200 micrograms film-coated tabletsShionogi · emc · SmPC §4.5 Interaction with other medicinal products · Version 5Document updated
Sources checked